Adverse Drug Events Observed with the Novel Sodium/Glucose Co-Transporter 2 Inhibitor Ipragliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Studies
Crossref DOI link: https://doi.org/10.1007/s12325-020-01471-2
Published Online: 2020-08-26
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Dan
Chen, Hao
Song, Fang
Ahmed, Mohamad Anis
Wu, Hongyan
Text and Data Mining valid from 2020-08-26
Version of Record valid from 2020-08-26
Article History
Received: 29 July 2020
First Online: 26 August 2020